Deepak Bahri

Over the past 33 years, the Sentiss group has grown exponentially with a diverse offering of Sterile products for global markets. Incorporated in 2013, Sentiss US (Sentiss Pharmaceuticals LLC) was established as the US subsidiary to create direct market presence. With an emphasis on expanding our pharmaceutical product offerings, we aim to serve US patients with a broad portfolio of quality Ophthalmic, Inhalation, Injectable, and specialty pharmaceutical products. At Sentiss we are committed to providing the best quality pharmaceutical products. Sentiss’ footprint on the world map is a testimony to its quality philosophy and value driven mantra with a focus on its award-winning culture. Sentiss strives to be a global leader as it continues to expand its operations globally.